The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
1Life Healthcare, Inc. | Common | 68269G107 | 633 | 31,266 | SH | SOLE | 31,266 | 0 | 0 | ||
Abbott Laboratories | Common | 002824100 | 77,616 | 657,038 | SH | SOLE | 657,038 | 0 | 0 | ||
AbbVie Inc. | Common | 00287Y109 | 56,547 | 524,213 | SH | SOLE | 524,213 | 0 | 0 | ||
Adaptive Biotechnologies Corp. | Common | 00650F109 | 11,479 | 337,722 | SH | SOLE | 337,722 | 0 | 0 | ||
Addus HomeCare Corp. | Common | 006739106 | 6,670 | 83,632 | SH | SOLE | 83,632 | 0 | 0 | ||
Affimed N.V. | Common | N01045108 | 3,622 | 586,038 | SH | SOLE | 586,038 | 0 | 0 | ||
Agilent Technologies, Inc. | Common | 00846U101 | 6,242 | 39,625 | SH | SOLE | 39,625 | 0 | 0 | ||
Align Technology, Inc. | Common | 016255101 | 4,963 | 7,459 | SH | SOLE | 7,459 | 0 | 0 | ||
Alkermes plc | Shares | G01767105 | 11,529 | 373,824 | SH | SOLE | 373,824 | 0 | 0 | ||
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 35,816 | 189,695 | SH | SOLE | 189,695 | 0 | 0 | ||
ALX Oncology Holdings Inc. | Common | 00166B105 | 524 | 7,099 | SH | SOLE | 7,099 | 0 | 0 | ||
Amgen Inc. | Common | 031162100 | 122,256 | 574,918 | SH | SOLE | 574,918 | 0 | 0 | ||
Amicus Therapeutics, Inc. | Common | 03152W109 | 5,608 | 587,277 | SH | SOLE | 587,277 | 0 | 0 | ||
Anthem, Inc. | Common | 036752103 | 5,459 | 14,644 | SH | SOLE | 14,644 | 0 | 0 | ||
Apellis Pharmaceuticals, Inc. | Common | 03753U106 | 6,454 | 195,820 | SH | SOLE | 195,820 | 0 | 0 | ||
ARCA biopharma, Inc. | Common | 00211Y506 | 96 | 32,461 | SH | SOLE | 32,461 | 0 | 0 | ||
Arcutis Biotherapeutics, Inc. | Common | 03969K108 | 3,145 | 131,633 | SH | SOLE | 131,633 | 0 | 0 | ||
Ardelyx, Inc. | Common | 039697107 | 712 | 539,408 | SH | SOLE | 539,408 | 0 | 0 | ||
Arena Pharmaceuticals, Inc. | Common | 040047607 | 4,980 | 83,629 | SH | SOLE | 83,629 | 0 | 0 | ||
argenx SE | Sponsored ADR | 04016X101 | 11,614 | 38,456 | SH | SOLE | 38,456 | 0 | 0 | ||
Arrowhead Pharmaceuticals, Inc. | Common | 04280A100 | 12,749 | 204,214 | SH | SOLE | 204,214 | 0 | 0 | ||
Arvinas, Inc. | Common | 04335A105 | 7,067 | 85,997 | SH | SOLE | 85,997 | 0 | 0 | ||
Ascendis Pharma A/S | Sponsored ADR | 04351P101 | 10,806 | 67,794 | SH | SOLE | 67,794 | 0 | 0 | ||
Assertio Holdings, Inc. | Common | 04546C205 | 372 | 410,575 | SH | SOLE | 410,575 | 0 | 0 | ||
AstraZeneca plc | Sponsored ADR | 046353108 | 48,824 | 812,927 | SH | SOLE | 812,927 | 0 | 0 | ||
Atreca, Inc. | Class A Common | 04965G109 | 1,429 | 229,372 | SH | SOLE | 229,372 | 0 | 0 | ||
Aurinia Pharmaceuticals Inc. | Common | 05156V102 | 5,595 | 252,821 | SH | SOLE | 252,821 | 0 | 0 | ||
Becton, Dickinson and Company | Common | 075887109 | 10,646 | 43,307 | SH | SOLE | 43,307 | 0 | 0 | ||
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 23,149 | 63,772 | SH | SOLE | 63,772 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | Common | 079481404 | 18 | 6,000 | SH | SOLE | 6,000 | 0 | 0 | ||
Bio-Techne Corp. | Common | 09073M104 | 2,617 | 5,400 | SH | SOLE | 5,400 | 0 | 0 | ||
Biogen Inc. | Common | 09062X103 | 66,178 | 233,853 | SH | SOLE | 233,853 | 0 | 0 | ||
Biohaven Pharmaceutical Holding Company Ltd. | Common | G11196105 | 12,613 | 90,799 | SH | SOLE | 90,799 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 9,893 | 128,004 | SH | SOLE | 128,004 | 0 | 0 | ||
BioNTech SE | Sponsored ADS | 09075V102 | 22,046 | 80,757 | SH | SOLE | 80,757 | 0 | 0 | ||
Black Diamond Therapeutics, Inc. | Common | 09203E105 | 1,117 | 131,990 | SH | SOLE | 131,990 | 0 | 0 | ||
Bolt Biotherapeutics, Inc. | Common | 097702104 | 823 | 65,025 | SH | SOLE | 65,025 | 0 | 0 | ||
Boston Scientific Corp. | Common | 101137107 | 8,068 | 185,931 | SH | SOLE | 185,931 | 0 | 0 | ||
Bristol-Myers Squibb Company | Common | 110122108 | 36,226 | 612,236 | SH | SOLE | 612,236 | 0 | 0 | ||
Caribou Biosciences, Inc. | Common | 142038108 | 15,621 | 699,377 | SH | SOLE | 699,377 | 0 | 0 | ||
Catalent, Inc. | Common | 148806102 | 19,151 | 143,913 | SH | SOLE | 143,913 | 0 | 0 | ||
Charles River Laboratories International, Inc. | Common | 159864107 | 32,388 | 78,484 | SH | SOLE | 78,484 | 0 | 0 | ||
ChemoCentryx, Inc. | Common | 16383L106 | 1,337 | 78,197 | SH | SOLE | 78,197 | 0 | 0 | ||
Cigna Corp. | Common | 125523100 | 44,383 | 221,740 | SH | SOLE | 221,740 | 0 | 0 | ||
Codexis, Inc. | Common | 192005106 | 1,871 | 80,448 | SH | SOLE | 80,448 | 0 | 0 | ||
Community Health Systems, Inc. | Common | 203668108 | 1,188 | 101,535 | SH | SOLE | 101,535 | 0 | 0 | ||
Community Healthcare Trust Inc. | Common | 20369C106 | 673 | 14,900 | SH | SOLE | 14,900 | 0 | 0 | ||
Corbus Pharmaceuticals Holdings, Inc. | Common | 21833P103 | 422 | 413,481 | SH | SOLE | 413,481 | 0 | 0 | ||
CRISPR Therapeutics AG | Namen AKT | H17182108 | 18,170 | 162,337 | SH | SOLE | 162,337 | 0 | 0 | ||
CVS Health Corp. | Common | 126650100 | 12,513 | 147,453 | SH | SOLE | 147,453 | 0 | 0 | ||
Danaher Corp. | Common | 235851102 | 45,265 | 148,683 | SH | SOLE | 148,683 | 0 | 0 | ||
Denali Therapeutics Inc. | Common | 24823R105 | 11,221 | 222,420 | SH | SOLE | 222,420 | 0 | 0 | ||
DENTSPLY SIRONA Inc. | Common | 24906P109 | 21,335 | 367,521 | SH | SOLE | 367,521 | 0 | 0 | ||
Dexcom, Inc. | Common | 252131107 | 23,504 | 42,980 | SH | SOLE | 42,980 | 0 | 0 | ||
Diversified Healthcare Trust | Common | 25525P107 | 1,213 | 357,720 | SH | SOLE | 357,720 | 0 | 0 | ||
Edwards Lifesciences Corp. | Common | 28176E108 | 22,034 | 194,630 | SH | SOLE | 194,630 | 0 | 0 | ||
Eli Lilly and Company | Common | 532457108 | 63,639 | 275,432 | SH | SOLE | 275,432 | 0 | 0 | ||
Endo International plc | Shares | G30401106 | 1,603 | 494,607 | SH | SOLE | 494,607 | 0 | 0 | ||
Exact Sciences Corp. | Common | 30063P105 | 21,503 | 225,282 | SH | SOLE | 225,282 | 0 | 0 | ||
Fate Therapeutics, Inc. | Common | 31189P102 | 4,311 | 72,727 | SH | SOLE | 72,727 | 0 | 0 | ||
Five Star Senior Living Inc. | Common | 33832D205 | 106 | 24,237 | SH | SOLE | 24,237 | 0 | 0 | ||
Forma Therapeutics Holdings, Inc. | Shares | 34633R104 | 3,474 | 149,825 | SH | SOLE | 149,825 | 0 | 0 | ||
Fulcrum Therapeutics, Inc. | Common | 359616109 | 1,238 | 43,898 | SH | SOLE | 43,898 | 0 | 0 | ||
Fusion Pharmaceuticals Inc. | Common | 36118A100 | 344 | 43,394 | SH | SOLE | 43,394 | 0 | 0 | ||
G1 Therapeutics, Inc. | Common | 3621LQ109 | 8,379 | 624,369 | SH | SOLE | 624,369 | 0 | 0 | ||
Galera Therapeutics, Inc. | Common | 36338D108 | 7,277 | 898,374 | SH | SOLE | 898,374 | 0 | 0 | ||
Gamida Cell Ltd. | Shares | M47364100 | 463 | 118,142 | SH | SOLE | 118,142 | 0 | 0 | ||
Gilead Sciences, Inc. | Common | 375558103 | 119,308 | 1,708,065 | SH | SOLE | 1,708,065 | 0 | 0 | ||
Global Medical REIT Inc. | Common | 37954A204 | 2,571 | 174,897 | SH | SOLE | 174,897 | 0 | 0 | ||
Guardant Health, Inc. | Common | 40131M109 | 48,502 | 387,984 | SH | SOLE | 387,984 | 0 | 0 | ||
HCA Healthcare, Inc. | Common | 40412C101 | 27,175 | 111,961 | SH | SOLE | 111,961 | 0 | 0 | ||
Health Care Select Sector SPDR Fund | SBI Healthcare | 81369Y209 | 16,909 | 132,830 | SH | SOLE | 132,830 | 0 | 0 | ||
Healthcare Realty Trust Inc. | Common | 421946104 | 3,098 | 104,024 | SH | SOLE | 104,024 | 0 | 0 | ||
Healthcare Trust of America, Inc. | Common | 42225P501 | 2,096 | 70,662 | SH | SOLE | 70,662 | 0 | 0 | ||
Healthpeak Properties, Inc. | Common | 42250P103 | 5,035 | 150,392 | SH | SOLE | 150,392 | 0 | 0 | ||
Helix Acquisition Corp. | Class A Common | G4444C102 | 2,468 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Hologic, Inc. | Common | 436440101 | 2,092 | 28,347 | SH | SOLE | 28,347 | 0 | 0 | ||
Horizon Therapeutics plc | Shares | G46188101 | 99,719 | 910,340 | SH | SOLE | 910,340 | 0 | 0 | ||
Humana Inc. | Common | 444859102 | 20,677 | 53,135 | SH | SOLE | 53,135 | 0 | 0 | ||
I-Mab | Sponsored ADS | 44975P103 | 11,785 | 162,580 | SH | SOLE | 162,580 | 0 | 0 | ||
Icon plc | Shares | G4705A100 | 25,906 | 98,871 | SH | SOLE | 98,871 | 0 | 0 | ||
IDEXX Laboratories, Inc. | Common | 45168D104 | 49,542 | 79,663 | SH | SOLE | 79,663 | 0 | 0 | ||
Illumina, Inc. | Common | 452327109 | 78,673 | 193,963 | SH | SOLE | 193,963 | 0 | 0 | ||
Intellia Therapeutics, Inc. | Common | 45826J105 | 7,805 | 58,180 | SH | SOLE | 58,180 | 0 | 0 | ||
Intercept Pharmaceuticals, Inc. | Common | 45845P108 | 773 | 52,067 | SH | SOLE | 52,067 | 0 | 0 | ||
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 12,094 | 324,401 | SH | SOLE | 324,401 | 0 | 0 | ||
Intuitive Surgical, Inc. | Common | 46120E602 | 19,885 | 20,002 | SH | SOLE | 20,002 | 0 | 0 | ||
Ionis Pharmaceuticals, Inc. | Common | 462222100 | 10,817 | 322,521 | SH | SOLE | 322,521 | 0 | 0 | ||
IQVIA Holdings Inc. | Common | 46266C105 | 18,359 | 76,644 | SH | SOLE | 76,644 | 0 | 0 | ||
iTeos Therapeutics, Inc. | Common | 46565G104 | 1,144 | 42,362 | SH | SOLE | 42,362 | 0 | 0 | ||
Jazz Pharmaceuticals plc | Shares | G50871105 | 14,852 | 114,059 | SH | SOLE | 114,059 | 0 | 0 | ||
Johnson & Johnson | Common | 478160104 | 83,439 | 516,652 | SH | SOLE | 516,652 | 0 | 0 | ||
KalVista Pharmaceuticals, Inc. | Common | 483497103 | 1,745 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Karuna Therapeutics, Inc. | Common | 48576A100 | 12,289 | 100,458 | SH | SOLE | 100,458 | 0 | 0 | ||
Koninklijke Philips N.V. | NY Reg Shares | 500472303 | 7,323 | 164,790 | SH | SOLE | 164,790 | 0 | 0 | ||
Kura Oncology, Inc. | Common | 50127T109 | 5,122 | 273,463 | SH | SOLE | 273,463 | 0 | 0 | ||
Laboratory Corporation of America Holdings | Sponsored ADR | 50540R409 | 26,640 | 94,656 | SH | SOLE | 94,656 | 0 | 0 | ||
LTC Properties, Inc. | Common | 502175102 | 5,777 | 182,293 | SH | SOLE | 182,293 | 0 | 0 | ||
McKesson Corp. | Common | 58155Q103 | 36,203 | 181,577 | SH | SOLE | 181,577 | 0 | 0 | ||
Medical Properties Trust, Inc. | Common | 58463J304 | 8,264 | 411,743 | SH | SOLE | 411,743 | 0 | 0 | ||
Medpace Holdings, Inc. | Common | 58506Q109 | 3,572 | 18,871 | SH | SOLE | 18,871 | 0 | 0 | ||
Medtronic plc | Shares | G5960L103 | 75,301 | 600,722 | SH | SOLE | 600,722 | 0 | 0 | ||
Merck & Co., Inc. | Common | 58933Y105 | 61,313 | 816,305 | SH | SOLE | 816,305 | 0 | 0 | ||
Mereo BioPharma Group plc | ADS | 589492107 | 3,754 | 1,551,082 | SH | SOLE | 1,551,082 | 0 | 0 | ||
Mettler-Toledo International Inc. | Common | 592688105 | 9,159 | 6,650 | SH | SOLE | 6,650 | 0 | 0 | ||
Mirati Therapeutics, Inc. | Common | 60468T105 | 14,822 | 83,784 | SH | SOLE | 83,784 | 0 | 0 | ||
Moderna, Inc. | Common | 60770K107 | 176,826 | 459,456 | SH | SOLE | 459,456 | 0 | 0 | ||
Molina Healthcare, Inc. | Common | 60855R100 | 22,688 | 83,625 | SH | SOLE | 83,625 | 0 | 0 | ||
Morphic Holding, Inc. | Common | 61775R105 | 1,984 | 35,025 | SH | SOLE | 35,025 | 0 | 0 | ||
MorphoSys AG | Sponsored ADS | 617760202 | 963 | 81,867 | SH | SOLE | 81,867 | 0 | 0 | ||
National Health Investors, Inc. | Common | 63633D104 | 537 | 10,038 | SH | SOLE | 10,038 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | Common | 64125C109 | 11,951 | 124,609 | SH | SOLE | 124,609 | 0 | 0 | ||
Nkarta, Inc. | Common | 65487U108 | 806 | 28,988 | SH | SOLE | 28,988 | 0 | 0 | ||
Novartis AG | Sponsored ADR | 66987V109 | 11,140 | 136,225 | SH | SOLE | 136,225 | 0 | 0 | ||
Novavax, Inc. | Common | 670002401 | 31,406 | 151,491 | SH | SOLE | 151,491 | 0 | 0 | ||
Novo Nordisk A/S | Sponsored ADR | 670100205 | 9,188 | 95,703 | SH | SOLE | 95,703 | 0 | 0 | ||
Omega Healthcare Investors, Inc. | Common | 681936100 | 9,181 | 306,433 | SH | SOLE | 306,433 | 0 | 0 | ||
Organon & Co. | Common | 68622V106 | 122 | 3,717 | SH | SOLE | 3,717 | 0 | 0 | ||
Owens & Minor, Inc. | Common | 690732102 | 9,230 | 294,967 | SH | SOLE | 294,967 | 0 | 0 | ||
PerkinElmer, Inc. | Common | 714046109 | 5,796 | 33,444 | SH | SOLE | 33,444 | 0 | 0 | ||
Perrigo Company plc | Shares | G97822103 | 2,424 | 51,224 | SH | SOLE | 51,224 | 0 | 0 | ||
Pfizer Inc. | Common | 717081103 | 19,371 | 450,379 | SH | SOLE | 450,379 | 0 | 0 | ||
Physicians Realty Trust | Common | 71943U104 | 8,735 | 495,733 | SH | SOLE | 495,733 | 0 | 0 | ||
Praxis Precision Medicines, Inc. | Common | 74006W108 | 1,387 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
Precision BioSciences, Inc. | Common | 74019P108 | 727 | 63,001 | SH | SOLE | 63,001 | 0 | 0 | ||
Protagonist Therapeutics, Inc. | Common | 74366E102 | 1,528 | 86,237 | SH | SOLE | 86,237 | 0 | 0 | ||
Qiagen N.V. | Shares | N72482123 | 5,574 | 107,855 | SH | SOLE | 107,855 | 0 | 0 | ||
R1 RCM Inc. | Common | 749397105 | 4,454 | 202,351 | SH | SOLE | 202,351 | 0 | 0 | ||
Rallybio Corp. | Common | 75120L100 | 37,608 | 2,308,672 | SH | SOLE | 2,308,672 | 0 | 0 | ||
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 89,576 | 148,015 | SH | SOLE | 148,015 | 0 | 0 | ||
ResMed Inc. | Common | 761152107 | 3,740 | 14,189 | SH | SOLE | 14,189 | 0 | 0 | ||
Sabra Health Care REIT, Inc. | Common | 78573L106 | 7,517 | 510,660 | SH | SOLE | 510,660 | 0 | 0 | ||
Sanofi | Sponsored ADR | 80105N105 | 7,388 | 153,254 | SH | SOLE | 153,254 | 0 | 0 | ||
Sarepta Therapeutics, Inc. | Common | 803607100 | 39,444 | 426,514 | SH | SOLE | 426,514 | 0 | 0 | ||
Scholar Rock Holding Corp. | Common | 80706P103 | 3,594 | 108,833 | SH | SOLE | 108,833 | 0 | 0 | ||
Seagen Inc. | Common | 81181C104 | 35,205 | 207,334 | SH | SOLE | 207,334 | 0 | 0 | ||
Smith & Nephew plc | Sponsored ADR | 83175M205 | 6,240 | 181,710 | SH | SOLE | 181,710 | 0 | 0 | ||
Spectrum Pharmaceuticals, Inc. | Common | 84763A108 | 250 | 114,670 | SH | SOLE | 114,670 | 0 | 0 | ||
STERIS plc | Shares | G8473T100 | 3,405 | 16,669 | SH | SOLE | 16,669 | 0 | 0 | ||
Stevanato Group SpA | Shares | T9224W109 | 3,490 | 137,872 | SH | SOLE | 137,872 | 0 | 0 | ||
Stoke Therapeutics, Inc. | Common | 86150R107 | 2,525 | 99,263 | SH | SOLE | 99,263 | 0 | 0 | ||
Stryker Corp. | Common | 863667101 | 39,690 | 150,500 | SH | SOLE | 150,500 | 0 | 0 | ||
Sutro Biopharma, Inc. | Common | 869367102 | 7,559 | 400,147 | SH | SOLE | 400,147 | 0 | 0 | ||
Syneos Health, Inc. | Class A | 87166B102 | 21,313 | 243,633 | SH | SOLE | 243,633 | 0 | 0 | ||
Takeda Pharmaceutical Company Ltd. | Sponsored ADS | 874060205 | 3,442 | 210,146 | SH | SOLE | 210,146 | 0 | 0 | ||
TCR2 Therapeutics Inc. | Common | 87808K106 | 2,007 | 235,808 | SH | SOLE | 235,808 | 0 | 0 | ||
Teva Pharmaceutical Industries Ltd. | Sponsored ADR | 881624209 | 5,919 | 607,651 | SH | SOLE | 607,651 | 0 | 0 | ||
Theravance Biopharma, Inc. | Common | G8807B106 | 4,857 | 656,296 | SH | SOLE | 656,296 | 0 | 0 | ||
Thermo Fisher Scientific Inc. | Common | 883556102 | 83,480 | 146,116 | SH | SOLE | 146,116 | 0 | 0 | ||
Travere Therapeutics, Inc. | Common | 89422G107 | 5,162 | 212,869 | SH | SOLE | 212,869 | 0 | 0 | ||
TScan Therapeutics, Inc. | Common | 89854M101 | 1,668 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Turning Point Therapeutics, Inc. | Common | 90041T108 | 7,927 | 119,324 | SH | SOLE | 119,324 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 12,692 | 140,726 | SH | SOLE | 140,726 | 0 | 0 | ||
uniQure N.V. | Shares | N90064101 | 7,587 | 237,008 | SH | SOLE | 237,008 | 0 | 0 | ||
United Therapeutics Corp. | Class B | 91307C102 | 26,753 | 144,940 | SH | SOLE | 144,940 | 0 | 0 | ||
Unitedhealth Group Inc. | Common | 91324P102 | 119,617 | 306,129 | SH | SOLE | 306,129 | 0 | 0 | ||
Universal Health Realty Income Trust | Shares | 91359E105 | 622 | 11,258 | SH | SOLE | 11,258 | 0 | 0 | ||
Universal Health Services, Inc. | Class B | 913903100 | 8,305 | 60,023 | SH | SOLE | 60,023 | 0 | 0 | ||
VectivBio Holding AG | Shares | H9060V101 | 5,372 | 756,502 | SH | SOLE | 756,502 | 0 | 0 | ||
Ventas, Inc. | Common | 92276F100 | 13,699 | 248,131 | SH | SOLE | 248,131 | 0 | 0 | ||
Verona Pharma plc | Sponsored ADR | 925050106 | 4,120 | 751,905 | SH | SOLE | 751,905 | 0 | 0 | ||
Vertex Pharmaceuticals Inc. | Common | 92532F100 | 49,528 | 273,046 | SH | SOLE | 273,046 | 0 | 0 | ||
Vir Biotechnology, Inc. | Common | 92764N102 | 3,543 | 81,400 | SH | SOLE | 81,400 | 0 | 0 | ||
VYNE Therapeutics Inc. | Common | 92941V209 | 188 | 135,395 | SH | SOLE | 135,395 | 0 | 0 | ||
Waters Corp. | Common | 941848103 | 10,169 | 28,461 | SH | SOLE | 28,461 | 0 | 0 | ||
Welltower Inc. | Common | 95040Q104 | 16,734 | 203,083 | SH | SOLE | 203,083 | 0 | 0 | ||
West Pharmaceutical Services, Inc. | Common | 955306105 | 2,649 | 6,240 | SH | SOLE | 6,240 | 0 | 0 | ||
Xenon Pharmaceuticals Inc. | Common | 98420N105 | 2,583 | 169,030 | SH | SOLE | 169,030 | 0 | 0 | ||
Zai Lab Ltd. | ADR | 98887Q104 | 3,955 | 37,523 | SH | SOLE | 37,523 | 0 | 0 | ||
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 32,595 | 222,703 | SH | SOLE | 222,703 | 0 | 0 | ||
Zoetis Inc. | Class A | 98978V103 | 27,684 | 142,597 | SH | SOLE | 142,597 | 0 | 0 | ||
Zogenix, Inc. | Common | 98978L204 | 1,352 | 88,977 | SH | SOLE | 88,977 | 0 | 0 |